UG Healthcare Corporation Limited (SGX:8K7)
Singapore · Delayed Price · Currency is SGD 0.0920
0.00 (0.00%)
At close: Feb 27, 2026
UG Healthcare Corporation Income Statement
Financials in millions SGD. Fiscal year is July - June.
Millions SGD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
| 146.09 | 144.07 | 115.21 | 101.13 | 232.6 | 338.4 | |
Revenue Growth (YoY) | 5.73% | 25.06% | 13.91% | -56.52% | -31.27% | 134.66% |
Cost of Revenue | 111.85 | 109.34 | 89.34 | 99.69 | 148.21 | 142.24 |
Gross Profit | 34.24 | 34.74 | 25.87 | 1.45 | 84.39 | 196.16 |
Selling, General & Admin | 36.08 | 35.55 | 32.49 | 26.57 | 33.22 | 40.37 |
Operating Expenses | 36.08 | 35.55 | 32.49 | 26.57 | 33.22 | 40.37 |
Operating Income | -1.84 | -0.82 | -6.63 | -25.12 | 51.17 | 155.79 |
Interest Expense | -2.48 | -2.19 | -1.28 | -0.92 | -0.81 | -0.6 |
Interest & Investment Income | 0.79 | 0.79 | 2.01 | 2.15 | 0.43 | 0.11 |
Earnings From Equity Investments | 0.03 | -0.04 | -0.08 | 0.56 | 0.1 | 3.58 |
Currency Exchange Gain (Loss) | 1.19 | -0.08 | -3.06 | 0.37 | - | 0.99 |
Other Non Operating Income (Expenses) | 0.65 | 0.36 | 2.04 | -0.08 | -2.15 | -0.46 |
EBT Excluding Unusual Items | -1.65 | -1.96 | -6.99 | -23.03 | 48.74 | 159.4 |
Impairment of Goodwill | -1 | -1 | - | - | - | - |
Gain (Loss) on Sale of Assets | - | - | - | - | 0.02 | - |
Asset Writedown | -0.78 | -0.78 | - | -5.33 | - | - |
Pretax Income | -3.43 | -3.74 | -6.99 | -28.36 | 48.76 | 159.4 |
Income Tax Expense | 0.62 | 0.98 | -0.31 | -1.4 | 8.96 | 39.46 |
Earnings From Continuing Operations | -4.04 | -4.72 | -6.68 | -26.96 | 39.8 | 119.94 |
Minority Interest in Earnings | -0.26 | 0.63 | 2.73 | 6.23 | -3 | -1.18 |
Net Income | -4.31 | -4.1 | -3.96 | -20.73 | 36.8 | 118.77 |
Net Income to Common | -4.31 | -4.1 | -3.96 | -20.73 | 36.8 | 118.77 |
Net Income Growth | - | - | - | - | -69.02% | 786.17% |
Shares Outstanding (Basic) | 624 | 624 | 624 | 624 | 620 | 611 |
Shares Outstanding (Diluted) | 624 | 624 | 624 | 624 | 620 | 611 |
Shares Change (YoY) | - | - | - | 0.58% | 1.43% | 3.24% |
EPS (Basic) | -0.01 | -0.01 | -0.01 | -0.03 | 0.06 | 0.19 |
EPS (Diluted) | -0.01 | -0.01 | -0.01 | -0.03 | 0.06 | 0.19 |
EPS Growth | - | - | - | - | -69.45% | 759.42% |
Free Cash Flow | 5.48 | -6.05 | -11.1 | -44.7 | 33.21 | 63.19 |
Free Cash Flow Per Share | 0.01 | -0.01 | -0.02 | -0.07 | 0.05 | 0.10 |
Dividend Per Share | - | - | - | - | 0.003 | 0.004 |
Dividend Growth | - | - | - | - | -21.18% | 70.59% |
Gross Margin | 23.44% | 24.11% | 22.45% | 1.43% | 36.28% | 57.97% |
Operating Margin | -1.26% | -0.57% | -5.75% | -24.84% | 22.00% | 46.04% |
Profit Margin | -2.95% | -2.84% | -3.44% | -20.50% | 15.82% | 35.10% |
Free Cash Flow Margin | 3.75% | -4.20% | -9.63% | -44.20% | 14.28% | 18.67% |
EBITDA | 2.72 | 2.3 | -3.45 | -22.41 | 54.21 | 158.28 |
EBITDA Margin | 1.86% | 1.60% | -3.00% | -22.16% | 23.31% | 46.77% |
D&A For EBITDA | 4.56 | 3.12 | 3.18 | 2.71 | 3.05 | 2.49 |
EBIT | -1.84 | -0.82 | -6.63 | -25.12 | 51.17 | 155.79 |
EBIT Margin | -1.26% | -0.57% | -5.75% | -24.84% | 22.00% | 46.04% |
Effective Tax Rate | - | - | - | - | 18.38% | 24.75% |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.